Eiger BioPharmaceuticals, Inc. (EIGRQ)

Eiger BioPharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	25.44	25.44	25.8	22.22	28.86	39.37
Short-Term Investments	0.4	0.4	77.69	66.65	99.98	55.62
Cash & Short-Term Investments	25.84	25.84	103.49	88.87	128.84	94.99
Cash Growth	-75.03%	-75.03%	16.45%	-31.02%	35.63%	-5.34%
Receivables	1.68	1.68	1.75	2.58	-	-
Inventory	1.56	1.56	2.85	2.61	0.09	-
Prepaid Expenses	7.47	7.47	7.7	8.05	7.75	3.42
Other Current Assets	1.29	1.29	1.74	1.26	1.12	1.97
Total Current Assets	37.84	37.84	117.54	103.36	137.81	100.38
Property, Plant & Equipment	0.63	0.63	0.7	1.27	1.89	2.24
Long-Term Investments	-	-	-	17.26	-	-
Other Long-Term Assets	0.36	0.36	1.91	4.51	3.9	2.51
Total Assets	38.83	38.83	120.14	126.4	143.59	105.14
Accounts Payable	2.12	2.12	8.98	7.77	4.64	6.41
Accrued Expenses	7.69	7.69	14.28	11.85	11.41	10
Current Portion of Long-Term Debt	41.12	41.12	-	7.81	-	-
Current Portion of Leases	0.08	0.08	0.49	0.63	0.58	0.53
Current Unearned Revenue	2.28	2.28	1.37	1.85	-	-
Total Current Liabilities	53.28	53.28	25.12	29.9	16.63	16.95
Long-Term Debt	-	-	39.63	23.99	31.19	30.39
Long-Term Leases	-	-	0.08	0.12	0.74	1.32
Total Liabilities	53.28	53.28	64.83	54	48.56	48.66
Common Stock	0	0	0	0.04	0.03	0.02
Additional Paid-In Capital	497.87	497.87	492.8	412.93	401.51	297.86
Retained Earnings	-512.16	-512.16	-437.19	-340.42	-306.5	-241.45
Comprehensive Income & Other	-0.17	-0.17	-0.3	-0.15	-0.01	0.04
Total Common Equity	-14.46	-14.46	55.31	72.4	95.04	56.48
Shareholders' Equity	-14.46	-14.46	55.31	72.4	95.04	56.48
Total Liabilities & Equity	38.83	38.83	120.14	126.4	143.59	105.14
Total Debt	41.2	41.2	40.2	32.54	32.51	32.24
Net Cash (Debt)	-15.36	-15.36	63.29	56.33	96.33	62.75
Net Cash Growth	-	-	12.36%	-41.52%	53.51%	-16.03%
Net Cash Per Share	-10.40	-10.40	45.61	49.78	102.68	82.62
Filing Date Shares Outstanding	1.48	1.48	1.47	1.15	1.13	0.82
Total Common Shares Outstanding	1.48	1.48	1.47	1.15	1.13	0.82
Working Capital	-15.45	-15.45	92.41	73.46	121.18	83.44
Book Value Per Share	-9.77	-9.77	37.65	62.83	84.16	69.09
Tangible Book Value	-14.46	-14.46	55.31	72.4	95.04	56.48
Tangible Book Value Per Share	-9.77	-9.77	37.65	62.83	84.16	69.09
Machinery	1.39	1.39	1.12	1.06	0.9	0.31
Construction In Progress	0.31	0.31	0.37	0.06	0.07	0.44
Leasehold Improvements	0.1	0.1	0.1	0.1	0.08	0.06

Source: S&P Capital IQ. Standard template. Financial Sources.